[PDF][PDF] Research Progress on Anti-Tumor Active Ingredients and Anti-Tumor Mechanism of Cordyceps militaris
T Xiang, C Xia, J Shen, C Wang - Hans. J. Food Nut. Sci, 2019 - pdf.hanspub.org
… or indirect anti-tumor mechanism is classified and summarized, including inhibition of sputum,
… 细胞周期蛋白依赖性激酶(cyclin-dependent kinases, CDKs)是目前研究 的热点,它可以在细胞…
… 细胞周期蛋白依赖性激酶(cyclin-dependent kinases, CDKs)是目前研究 的热点,它可以在细胞…
卵巢Brenner 瘤研究进展.
万桃, 俞萍源, 邢义涓, 王黎… - Journal of International …, 2023 - search.ebscohost.com
… 激酶抑制因子2A (cyclin-dependent kinase inhibitor 2A,CDKN2A)及… Statins exert anti-tumor
effects and improve the … and enhance the anti-tumor effects of chemotherapy drugs, and …
effects and improve the … and enhance the anti-tumor effects of chemotherapy drugs, and …
Dipeptidyl peptidase‐4 inhibitors: Multitarget drugs, not only antidiabetes drugs (D ipeptidyl peptidase‐4 抑制剂: 多靶点药物, 不仅仅是降糖药)
Y Zhao, L Yang, Z Zhou - Journal of Diabetes, 2014 - Wiley Online Library
… of cyclin-dependent kinase 2, and dephosphorylation of retinoblastoma substrate42 … -dependent
cell-mediated cytotoxicity and direct anti-tumor effect via p27 kip1 accumulation43 …
cell-mediated cytotoxicity and direct anti-tumor effect via p27 kip1 accumulation43 …
3, 3'-二吲哚甲烷在卵巢癌細胞中之抗細胞增生作用
陳怡雯 - 2010 - airitilibrary.com
… to exhibit anti-tumor … in Cyclin dependent kinases inhibitors (p21, and/or p27). In summary,
these findings suggest that DIM may be a potential chemopreventive and therapeutic agent …
these findings suggest that DIM may be a potential chemopreventive and therapeutic agent …
[HTML][HTML] 源于天然产物或其衍生物的分子靶向抗肿瘤药物研究进展
张旭, 蒙凌华 - 药学学报, 2020 - html.rhhz.net
… At present, a number of molecularly targeted anti-tumor drugs … the molecularly targeted
anti-tumor drugs derived from natural … Recent advances in cyclin-dependent kinase inhibitors with …
anti-tumor drugs derived from natural … Recent advances in cyclin-dependent kinase inhibitors with …
[HTML][HTML] 蛋白酶体亚基对肝细胞癌发生发展的调控作用研究进展
HU Jingyi, W Qingqing, LIU Yang - Journal of Zhejiang University …, 2021 - ncbi.nlm.nih.gov
… mediator of cell death (Bim), cyclin-dependent kinase 4(CDK4), transforming growth factor β
… -related proteins, so inhibitors targeting the core particle show a good anti-tumor effect. This …
… -related proteins, so inhibitors targeting the core particle show a good anti-tumor effect. This …
2022 年改变晚期乳腺癌临床实践的重要研究
张会强, 江泽飞 - 中国癌症杂志, 2023 - china-oncology.com
… cancer and the continuous development of anti-tumor drugs, the survival time of breast …
who have failed treatment with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors. Novel anti-…
who have failed treatment with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors. Novel anti-…
[HTML][HTML] 乳腺癌相关治疗中细胞周期蛋白依赖性激酶4 和6 抑制剂机制相关的研究进展
乌尔肯, 甫拉提 - Advances in Clinical Medicine, 2023 - hanspub.org
… Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are cell-targeted agents, and their
combination with endocrine therapy agents … Although CDK4/6 inhibitors have been well used in …
combination with endocrine therapy agents … Although CDK4/6 inhibitors have been well used in …
[PDF][PDF] CDK4/6 抑制剂在HR 阳性/HER2 阴性乳腺癌新辅助治疗中的研究进展
肖红艳, 张丽娜, 顾林 - 肿瘤, 2022 - tumorsci.org
… of single agent neoadjuvant therapy with CDK4/6 inhibitor in … marker of cyclindependent
kinase 4/6 inhibition in patients with … A phase I study of the cyclin-dependent kinase 4/6 inhibitor …
kinase 4/6 inhibition in patients with … A phase I study of the cyclin-dependent kinase 4/6 inhibitor …